Incidence rate and occurrence of visually significant cataract formation and corneal decompensation after implantation of Verisyse/Artisan phakic intraocular lens
A 53-year-old woman was referred in 2003 for correction of high myopia, with SE of −15.75 and −14.375 in the right and left eyes, respectively. The patient underwent uncomplicated pIOL implantation in both eyes, 9 months apart, as part of the Verisyse FDA clinical trial. At 2-year follow-up, the CDVA was 20/20 with SE of 0.125 in the right eye, and 20/20−2 with SE of 0.625 in the left eye. Seven years after implantation of the right pIOL, the patient was found on annual exam to have developed trace nuclear sclerosis in the right eye. Two years later, right CDVA was 20/50−2 and left CDVA was 20/25−2. Slit-lamp examination identified 2+ nuclear sclerosis and PSC in the right eye, and a 1−2+ NSC in the left eye. There were no known comorbidities in this patient. The patient subsequently underwent right pIOL explantation and cataract extraction, with PCIOL placement. At the most recent follow-up, 2 weeks after surgery, the patient’s CDVA was 20/20 in the right eye, and SE was −0.75.